Comparison of Non-mydriatic Camera Systems in a Female Health Hospital
NCT ID: NCT02089009
Last Updated: 2016-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
214 participants
INTERVENTIONAL
2013-12-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. To compare the retinal vessel diameters based on the images of to different camera-systems.
3. To detect changes in retinal vessel diameters while pregnancy and after delivery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monochromatic Digital-Pupillometry With Two Automated Devices in Comparison to Manual Measurements on Digital Photographs
NCT02978092
OCT and OCT-A Afer Diabetic Vitrectomy in PDR
NCT05938491
Quality and Diagnostic Utility of Mydriatic Fundus Plenoptic Photography
NCT03037268
Multimodal Imaging of Retinal Vessels
NCT02717026
Macular Appearance After Diabetic Vitrectomy
NCT00737022
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Quality means in this content that images cover the planned region of interest and images should be sharp and good illuminated to see details for medical reading of retinal findings.
2. To compare the retinal vessel diameters based on the images of to different camera-systems.
The diameters of arteries and veins are planned to be measured with an automated software algorithm. Are there differences in the calculated results between the two used camera devices?
3. To detect changes in retinal vessel diameters while pregnancy and after delivery.
Are there detectable changes of the retinal findings between the images taken before and after delivery (e.g. bleeding, edema, vessel tortuosity)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 Standard Population
Retinal Imaging, vessel measurements, vessel changes of a population of a female health hospital
Retinal imaging
Retinal imaging by using non-mydriatic camera devices
Vessel measurements
Vessel measurements based on the taken images by the use of a specialized software
Change in vessel diameters
Change of vessel diameters before and after delivery based on the taken images by the use of a specialized software
Group 2 Pregnant Population
Change in vessel diameter at perinatal visits with retinal imaging (Retinal Imaging, vessel measurements, vessel changes)
Retinal imaging
Retinal imaging by using non-mydriatic camera devices
Vessel measurements
Vessel measurements based on the taken images by the use of a specialized software
Change in vessel diameters
Change of vessel diameters before and after delivery based on the taken images by the use of a specialized software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Retinal imaging
Retinal imaging by using non-mydriatic camera devices
Vessel measurements
Vessel measurements based on the taken images by the use of a specialized software
Change in vessel diameters
Change of vessel diameters before and after delivery based on the taken images by the use of a specialized software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \>18 years
* pregnancy (only group 2)
Exclusion Criteria
* heavy tremble
* reduced general condition
* known epilepsy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optomed
UNKNOWN
Dr. Martin Leitritz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Martin Leitritz
Dr. med. Martin A. Leitritz
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin A Leitritz, M.D.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tuebingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Female Health Hospital Reutlingen
Reutlingen, Baden-Wurttemberg, Germany
University Eye Hospital
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NonMydGyn
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.